Table of Content


Introduction
Non Alcoholic Fatty Liver Disease (FLD) - Overview
Non Alcoholic Fatty Liver Disease (FLD) - Therapeutics Development
Non Alcoholic Fatty Liver Disease (FLD) - Therapeutics Assessment
Non Alcoholic Fatty Liver Disease (FLD) - Companies Involved in Therapeutics Development
Non Alcoholic Fatty Liver Disease (FLD) - Drug Profiles
Non Alcoholic Fatty Liver Disease (FLD) - Dormant Projects
Non Alcoholic Fatty Liver Disease (FLD) - Discontinued Products
Non Alcoholic Fatty Liver Disease (FLD) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Non Alcoholic Fatty Liver Disease (NAFLD), H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products by Top 10 Targets, H1 2019
Number of Products by Stage and Top 10 Targets, H1 2019
Number of Products by Top 10 Mechanism of Actions, H1 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
Number of Products by Routes of Administration, H1 2019
Number of Products by Stage and Routes of Administration, H1 2019
Number of Products by Top 10 Molecule Types, H1 2019
Number of Products by Stage and Top 10 Molecule Types, H1 2019


List of Tables


Number of Products under Development for Non Alcoholic Fatty Liver Disease (NAFLD), H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Universities/Institutes, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Akcea Therapeutics Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Ardelyx Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by AstraZeneca Plc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Betagenon AB, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by BioElectron Technology Corp, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Bird Rock Bio Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Boehringer Ingelheim GmbH, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Cadila Healthcare Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Can-Fite BioPharma Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Carmot Therapeutics Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Cerenis Therapeutics Holding SA, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Corcept Therapeutics Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Dr. Falk Pharma GmbH, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by DURECT Corp, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Eli Lilly and Co, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Enanta Pharmaceuticals Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Eternygen GmbH, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Evgen Pharma Plc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by F. Hoffmann-La Roche Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Galmed Pharmaceuticals Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Gemphire Therapeutics Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by GemVax & KAEL Co Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Gilead Sciences Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Hanmi Pharmaceuticals Co Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by HemoShear Therapeutics, LLC, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Huons Global Co Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Immuron Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Inventiva, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Ionis Pharmaceuticals Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kinomedica Pty Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kowa Co Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kyorin Pharmaceutical Co Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by MallInckrodt Plc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Metacrine Inc, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Mina Therapeutics Ltd, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Novartis AG, H1 2019
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by NuSirt Biopharma Inc, H1 2019